Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Hansa Biopharma AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 111,263 Less Arrow 90,068 More Arrow 103,259
Financial expenses 121,555 Less Arrow 70,875 Less Arrow 32,502
Earnings before taxes -601,248 More Arrow -558,035 More Arrow -407,608
EBITDA -403,802 Less Arrow -523,013 More Arrow -393,314
Total assets 1,339,570 Less Arrow 683,792 More Arrow 1,127,581
Current assets 366,189 More Arrow 574,383 More Arrow 1,072,317
Current liabilities 164,655 More Arrow 215,599 Less Arrow 176,891
Equity capital 438,027 Less Arrow -112,758 More Arrow 402,885
- share capital 44,042 Less Arrow 36,965 Less Arrow 36,776
Employees (average) 0 More Arrow 159 Less Arrow 144

Financial ratios

Fiscal year 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 32.7% Less Arrow -16.5% More Arrow 35.7%
Turnover per employee 566 More Arrow 717
Profit as a percentage of turnover -540.4% Less Arrow -619.6% More Arrow -394.7%
Return on assets (ROA) -35.8% Less Arrow -71.2% More Arrow -33.3%
Current ratio 222.4% More Arrow 266.4% More Arrow 606.2%
Return on equity (ROE) -137.3% More Arrow 494.9% Less Arrow -101.2%
Change turnover
Change turnover % -13% More Arrow 356%
Chg. No. of employees
Chg. No. of employees % 10% More Arrow 24%

Total value of public sale

Fiscal year 2024/12 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.